Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Appointed director
Receptos, Inc. (RCPT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/27/2015 8-K Quarterly results
07/15/2015 8-K Amended existing or entered into new employment agreement with an officer
Docs: "Agreement and Plan of Merger, by and among Celgene Corporation, Strix Corporation and Receptos, Inc",
"Form of Amendment to Employment Agreement",
"Tender and Support Agreement, by and among Celgene Corporation, Strix Corporation and each of the stockholders named therein"
07/14/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases"
06/01/2015 8-K Submission of Matters to a Vote of Security Holders
05/05/2015 8-K Quarterly results
Docs: "Receptos Provides Business Update and Reports First Quarter 2015 Financial Results"
04/16/2015 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Colitis"
03/03/2015 8-K Quarterly results
Docs: "Receptos Provides Development Updates and Reports Fourth Quarter and Year End 2014 Financial Results"
02/23/2015 8-K Investor presentation
Docs: "Slide presentation of Receptos, Inc."
02/18/2015 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "First Amendment to Lease, by and between Receptos, Inc. and ARE-SD Region No. 35, LLC",
"Second Amendment to Lease, by and between Receptos, Inc. and ARE-SD Region No. 35, LLC"
12/02/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/24/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Press release issued by Receptos, Inc."
11/19/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and between Receptos, Inc., Credit Suisse Securities (USA) LLC and Leerink Partners LLC, as Representatives for the several underwriters",
"Opinion of Pillsbury Winthrop Shaw Pittman LLP",
"Receptos Announces Pricing of Underwritten Public Offering of Common Stock"
11/04/2014 8-K Quarterly results
Docs: "Receptos Provides Development Updates and Reports Third Quarter 2014 Financial Results"
10/27/2014 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis"
09/15/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slide presentation of Receptos, Inc."
08/12/2014 8-K Quarterly results
Docs: "Receptos Reports Second Quarter 2014 Financial Results"
07/29/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Receptos Announces Appointment of Mary Szela and Richard Heyman, Ph.D. to Board of Directors San Diego, CA, July 29, 2014 — Receptos, Inc. , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced the appointment of Mary Szela and Richard Heyman to the board of directors of Receptos. Ms. Szela and Dr. Heyman will both serve as Class II directors with terms of office expiring and to be renewed at the 2015 annual meeting of stockholders. Ms. Szela and Dr. Heyman will also both serve as members of the Board's Nominating and Corporate Governance Committee. Bill Rastetter, Ph.D., chairman of the board of directors of Receptos, said, “We are pleased to welcome both Mary and Rich to the Receptos board of directors. Mary's e..."
06/24/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Receptos Announces Closing of Underwritten Public Offering of Common Stock"
06/09/2014 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis"
06/05/2014 8-K Submission of Matters to a Vote of Security Holders
05/12/2014 8-K Quarterly results
Docs: "Receptos Reports First Quarter 2014 Financial Results"
04/28/2014 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Lease Agreement, by and between Receptos, Inc. and ARE-SD Region No. 35, LLC"
04/14/2014 8-K Appointed a new director
Docs: "Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as Director San Diego, CA, April 14, 2014 — Receptos, Inc. , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced the appointment of Mary Lynne Hedley, Ph.D. as a director of Receptos. Dr. Hedley will serve as a Class I director with a term of office expiring and to be renewed at the 2014 annual meeting of stockholders. Dr. Hedley will also serve as a member of the Board's Nominating and Corporate Governance Committee. Dr. Hedley has served as president of Tesaro, Inc. and as a member of its Board of Directors since co-founding Tesaro in March 2010. From July 2009 to February 2010, Dr. Hedley served as executive vice president of operations and chief scien..."
03/05/2014 8-K Quarterly results
Docs: "Receptos Reports Fourth Quarter and Year End 2013 Operational and Financial Results"
02/03/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/14/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Press release issued by Receptos, Inc."
12/10/2013 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "FIRST AMENDMENT TO COLLABORATION AGREEMENT",
"Receptos and Ono Pharmaceuticals Expand Collaboration Agreement to Include Transfer of Receptos GPCR Technology Platform"
12/05/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Receptos to Initiate Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis"
11/26/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Press release issued by Receptos, Inc. on November 26, 2013"
10/30/2013 8-K Form 8-K - Current report
07/22/2013 8-K Appointed a new director
06/05/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Corporate slide presentation of Receptos, Inc."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy